LES hosts monthly webinars, as part of its ongoing Webinar Wednesdays series, as well as Hot Topic webinars that are periodically scheduled to cover breaking developments such as patent reform, important case updates and other major industry news. Webinar Wednesdays are held on the second Wednesday of each month at 1:00 p.m. Eastern Time and are also available anytime on-demand. Join IP and licensing experts as they share their knowledge and experience regarding today’s most relevant licensing trends and challenges from transactional issues to ethics to valuation.
*NEW LES member benefit: these webinars, a $1,200 value, are FREE for LES members in 2014. Click on a webinar below and register today!
Technology Valuation Concepts, Methods, and Applications – Part 2
December 10, 2014
As the second installment of a two part webinar series, this presentation will focus on unique applications of valuation in technology-based transactions. With reference to their own experiences, panelists from the Life Sciences and University-Government Interface sectors will discuss the intersection of valuation and transaction with specific reference to the transactions introduced in Part 1. Among other topics, this discussion will investigate the role of valuation in assessing, marketing, negotiating, and structuring technology-based transactions.
This webinar series is sponsored by the LES Valuation and Taxation Committee.
Antoine Bellemare, Technology Transfer Officer, Université Laval
Joe Dillon, President and CEO, SynerPhysics, Inc. and President, Dillon Capital Strategies
Chris Schulte, Director, 284 Partners
Dr. Bellemare is a technology transfer officer and patent committee member at the University-Industry Liaison Office of Université Laval and the president-founder of the technology management consulting firm Research Patent Management. With more than twenty years of experience in technology development in a wide array of environments from venture capital to university, and including a start-up company, a world-class company and a valorization company, he has a panoramic view on the issues relating to technology transfer and licensing. His principal expertise is in the strategic management of intellectual assets, structuring and negotiating of licence agreements, IP valuation, and the financing and management of technological projects. He holds a bachelor degree in physics engineering and a PhD in electrical engineering from Université Laval for work related to fiber laser technology. Dr. Bellemare has two patented inventions and several well-cited scientific publications to his credit and he also acts as a reviewer for five prestigious scientific publications: Photonics Technology Letters, Journal of Lightwave Technology, Applied Physics B: Lasers and Optics, Journal of Modern Optics and Journal of Quantum Electronics. In 2008, Dr. Bellemare has obtained the CLP designation from LES, where he serves as Founder and Co-Chairman of the Quebec City Chapter, Faculty for the IP & Licensing Basics course and Member of the Valuation and Taxation, LESI IP valuation and CLP Exam Development and Maintenance committees.
Joseph S. Dillon is President & CEO of SynerPhysics, Inc. and President of Dillon Capital Strategies, the strategy and business analytics advisory arm of SynerPhysics. Mr. Dillon is a seasoned pharmaceutical executive with over 20 years of experience. He has extensive experience in global pharmaceutical business planning and analysis, corporate finance, M&A, licensing, and technology valuations. Over the course of his career, Mr. Dillon has screened thousands of opportunities, valued over 300 deals and has been involved in over 40 closed transactions. Prior to forming SynerPhysics and Dillon Capital Strategies, Mr. Dillon held senior positions in two pharmaceutical management consulting firms, most significantly as Senior Vice President, Head of Corporate Development Services and Valuations for The Mattson Jack Group (now Kantar Health). Other previous positions include CEO, President, and Director of The Pharmaceutical Development Center, a pharmaceutical developer and manufacturer; Executive Vice President and CFO of Vail Banks Inc., a multi-bank holding company; CFO and Treasurer of Oread Inc., a contract pharmaceutical developer and manufacturer; and corporate positions with predecessor companies of Sanofi. Mr. Dillon is Past-Chairperson of the LES Life Sciences Sector Executive Committee. He is a veteran speaker at BIO, LES, WBR, EBD, and other prominent industry organization events. Mr. Dillon holds an M.B.A. in International Finance, a bachelors in Finance and has earned the Certified Licensing Professional (CLP) designation.
Christopher L. Schulte is a Director at 284 Partners, LLC, a professional services firm dedicated to advising clients and counsel on financial aspects of intellectual property, including valuation, litigation consulting, IP strategy, and IP transactions. Mr. Schulte has been a consultant focused on financial issues pertaining to intellectual property since 2003. His practice concentrates on the valuation of intellectual property and the determination of economic damages in intellectual property litigation. Mr. Schulte has consulted with clients regarding IP infringement damages and valuation issues associated with many types of intellectual property, including patents, trade secrets, trademarks, and copyrights. While the specific issues have varied from case to case, many of his past engagements have included an evaluation and analysis of financial and accounting data in order to quantify lost profits, reasonable royalties, price erosion, unjust enrichment, or diminished business value. Mr. Schulte has also provided analytical, strategic, and corporate finance support to clients engaged in licensing negotiations and other business transactions. Mr. Schulte holds a BBA with an emphasis in Finance from The University of Michigan Business School. Mr. Schulte is a CLP, the Chair of the Valuation and Taxation Committee of LES, Co-Chair of the Michigan Chapter of LES. He also serves on the Editorial Board for LES Insights and the CLP Exam Development Committee.
Who Should Attend
The webinars are designed for all IP and licensing professionals at any level of experience, including corporate IP and licensing professionals, technology transfer professionals, non-IP attorneys, and business development professionals.
Why You Should Attend
LES Webinars are a convenient and affordable way to stay up-to-date with current trends and challenges, gain core knowledge on IP and licensing topics, and supplement your learning in new areas. With our live webinars and growing library of on-demand webinars, you can log-in and learn from leading industry experts anywhere, anytime.
Each webinar is 60 or 90 minutes and addresses a unique topic presented by different industry experts. Sample topics include patent reform, trademark licensing, royalty auditing, patent sales agreements, antitrust issues, and patent licensing conflicts.
We are happy to announce the 2013 Webinar Wednesday series will be FREE to LES members! These webinars, delivered right to your desk, will provide increased knowledge and exposure to today’s hot topics. You’ll also be able to earn CLE and CLP credits!
This new member-only benefit gives you access to IP and licensing experts as they share their knowledge and experience regarding today’s most relevant licensing trends and challenges from transactional issues to ethics to valuation.